President Joe Biden recently addressed the issue of high drug costs in the United States during a discussion. The three companies have agreed to cap the price of asthma inhalers at $35, providing relief to Americans who rely on these medications. Biden emphasized that while he considers himself a capitalist, he believes that some actions by drug companies amount to exploitation.
Senator Bernie Sanders, an independent from Vermont, also highlighted the need to tackle the high cost of prescription drugs. He commended the efforts of the Biden administration and Democrats in Congress to push for lower drug prices, including implementing a price cap for seniors starting next year. Sanders stressed the importance of protecting Americans from being overcharged by pharmaceutical companies, especially in comparison to other countries.
The discussion coincided with the 10th anniversary of the Affordable Care Act, commonly known as Obamacare, which established government health care marketplaces for those without access to employer-sponsored plans. Data from the Kaiser Family Foundation showed that the average annual health care premium for single coverage in 2023 was $8,435, while family coverage averaged $23,968. Premiums have increased by 22% for both types of coverage since 2018.
During the most recent Open Enrollment Period, more than 21 million Americans either selected or were automatically re-enrolled in health insurance coverage through HealthCare.gov and state-based Marketplaces. The ongoing efforts to address high drug costs and make health care more affordable for Americans are crucial priorities for the Biden administration and lawmakers in Congress.
In conclusion, President Joe Biden’s recent address on high drug costs highlights how some actions by pharmaceutical companies can be exploitative. Senator Bernie Sanders emphasizes that this is an issue that needs addressing and commends efforts made so far by Democrats in Congress and President Biden’s administration towards lowering drug prices.
Furthermore, it is important to note that despite government healthcare marketplaces established under Obamacare providing access to healthcare for millions of people who previously had no insurance options; premiums have been steadily increasing since its implementation.
Therefore, addressing high drug costs and making healthcare more affordable remains a crucial priority for both President Biden’s administration and lawmakers in Congress as they continue their efforts towards ensuring equitable access to quality healthcare for all Americans.
